Myelodyplastic syndrome is mostly a genetic disease. There is no known environmental cause. More information can be found on Wikipedia and of course from your doctor.
Crosswicks, NJ
Myelodysplastic syndromes, also know as MDS, is a group of blood related disorders. These also involve ineffective production of blood cells of the myeloid class.
Myelodysplastic syndrome (MDS) is often referred to as preleukemia because it can progress to acute myeloid leukemia (AML) in some cases. MDS is a group of disorders where the bone marrow does not produce enough healthy blood cells.
Not unless your goal is to get aplastic amenia or MDS (myelodysplastic syndromes). Exposure to Benzene is a risk factor in developing these debilitating disease.
The cause of polyglandular deficiency syndromes is usually an autoimmune response
No you can not catch myelodysplastic anaemia from other people, as is the case for any type of anaemia. Myelodysplatic syndromes are characterised by ineffective production of myeloid blood cells (any white blood cell, excluding lymphocytes). Anaemia is a very common side effect of this type of disease. It is thought to be caused by exposure to environmental factors such as radiation. As it is caused by a defect in the production of blood cells, this can not be passed on from person to person.
There are many symptoms in myelodysplastic syndrome. Myelodyspalastic syndrome is when bone marrow doesn't produce enough blood cells for the body. Some of the more common symptoms are anemia, bleeding and infections.
Yes
noun; He had many syndromes.
The survival rate for Myelodysplastic Syndromes (MDS) varies widely depending on factors such as the specific subtype of MDS, the patient's age, overall health, and response to treatment. Generally, the median survival ranges from about 20 months to several years, with some patients living much longer, especially those who undergo successful treatment such as stem cell transplantation. Prognostic scoring systems, like the Revised International Prognostic Scoring System (IPSS-R), can help estimate individual survival chances. Regular monitoring and personalized treatment plans are crucial for improving outcomes.
myelodysplastic syndrome
myelodysplastic syndrome